| Product Code: ETC7051344 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Egypt Neuropathic Pain Market Overview |
3.1 Egypt Country Macro Economic Indicators |
3.2 Egypt Neuropathic Pain Market Revenues & Volume, 2021 & 2031F |
3.3 Egypt Neuropathic Pain Market - Industry Life Cycle |
3.4 Egypt Neuropathic Pain Market - Porter's Five Forces |
3.5 Egypt Neuropathic Pain Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Egypt Neuropathic Pain Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Egypt Neuropathic Pain Market Revenues & Volume Share, By Procedure, 2021 & 2031F |
3.8 Egypt Neuropathic Pain Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.9 Egypt Neuropathic Pain Market Revenues & Volume Share, By Modality, 2021 & 2031F |
3.10 Egypt Neuropathic Pain Market Revenues & Volume Share, By Mode of Purchase, 2021 & 2031F |
3.11 Egypt Neuropathic Pain Market Revenues & Volume Share, By Pain Type, 2021 & 2031F |
4 Egypt Neuropathic Pain Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases leading to neuropathic pain |
4.2.2 Growing awareness and diagnosis of neuropathic pain conditions |
4.2.3 Advancements in healthcare infrastructure and availability of treatment options in Egypt |
4.3 Market Restraints |
4.3.1 Limited access to specialized healthcare services for neuropathic pain |
4.3.2 High cost of neuropathic pain treatments and medications |
4.3.3 Lack of trained healthcare professionals in managing neuropathic pain effectively |
5 Egypt Neuropathic Pain Market Trends |
6 Egypt Neuropathic Pain Market, By Types |
6.1 Egypt Neuropathic Pain Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Egypt Neuropathic Pain Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Egypt Neuropathic Pain Market Revenues & Volume, By Spinal Cord Stimulation (SCS) Devices, 2021- 2031F |
6.1.4 Egypt Neuropathic Pain Market Revenues & Volume, By External Peripheral Nerve Stimulation, 2021- 2031F |
6.1.5 Egypt Neuropathic Pain Market Revenues & Volume, By Transcutaneous Electrical Nerve Stimulation (Tens) Devices, 2021- 2031F |
6.2 Egypt Neuropathic Pain Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Egypt Neuropathic Pain Market Revenues & Volume, By Rechargeable and Non-Rechargeable, 2021- 2031F |
6.3 Egypt Neuropathic Pain Market, By Procedure |
6.3.1 Overview and Analysis |
6.3.2 Egypt Neuropathic Pain Market Revenues & Volume, By Invasive and Non-Invasive, 2021- 2031F |
6.4 Egypt Neuropathic Pain Market, By Technology |
6.4.1 Overview and Analysis |
6.4.2 Egypt Neuropathic Pain Market Revenues & Volume, By Transcutaneous Electrical Nerve Stimulation, 2021- 2031F |
6.4.3 Egypt Neuropathic Pain Market Revenues & Volume, By Transcranial Magnetic Stimulation, 2021- 2031F |
6.4.4 Egypt Neuropathic Pain Market Revenues & Volume, By Respiratory Electrical Stimulation, 2021- 2031F |
6.5 Egypt Neuropathic Pain Market, By Modality |
6.5.1 Overview and Analysis |
6.5.2 Egypt Neuropathic Pain Market Revenues & Volume, By Stationary, 2021- 2031F |
6.5.3 Egypt Neuropathic Pain Market Revenues & Volume, By Portable, 2021- 2031F |
6.6 Egypt Neuropathic Pain Market, By Mode of Purchase |
6.6.1 Overview and Analysis |
6.6.2 Egypt Neuropathic Pain Market Revenues & Volume, By Over-the-Counter Devices, 2021- 2031F |
6.6.3 Egypt Neuropathic Pain Market Revenues & Volume, By Prescription-Based Devices, 2021- 2031F |
6.7 Egypt Neuropathic Pain Market, By Pain Type |
6.7.1 Overview and Analysis |
6.7.2 Egypt Neuropathic Pain Market Revenues & Volume, By Peripheral Neuropathy, 2021- 2031F |
6.7.3 Egypt Neuropathic Pain Market Revenues & Volume, By Entrapment Neuropathy, 2021- 2031F |
6.7.4 Egypt Neuropathic Pain Market Revenues & Volume, By Trigeminal Neuralgia, 2021- 2031F |
6.7.5 Egypt Neuropathic Pain Market Revenues & Volume, By Trigeminal Neuralgia, 2021- 2031F |
6.7.6 Egypt Neuropathic Pain Market Revenues & Volume, By Post Herpetic Neuralgia (PHN), 2021- 2031F |
6.7.7 Egypt Neuropathic Pain Market Revenues & Volume, By Post Traumatic Neuropathy, 2021- 2031F |
6.7.8 Egypt Neuropathic Pain Market Revenues & Volume, By Coccydynia, 2021- 2031F |
6.7.9 Egypt Neuropathic Pain Market Revenues & Volume, By Coccydynia, 2021- 2031F |
6.8 Egypt Neuropathic Pain Market, By Indication |
6.8.1 Overview and Analysis |
6.8.2 Egypt Neuropathic Pain Market Revenues & Volume, By Spinal Stenosis, 2021- 2031F |
6.8.3 Egypt Neuropathic Pain Market Revenues & Volume, By Chemotherapy-Induced Peripheral Neuropathy, 2021- 2031F |
6.8.4 Egypt Neuropathic Pain Market Revenues & Volume, By Others, 2021- 2031F |
6.8.5 Egypt Neuropathic Pain Market Revenues & Volume, By Others, 2021- 2031F |
7 Egypt Neuropathic Pain Market Import-Export Trade Statistics |
7.1 Egypt Neuropathic Pain Market Export to Major Countries |
7.2 Egypt Neuropathic Pain Market Imports from Major Countries |
8 Egypt Neuropathic Pain Market Key Performance Indicators |
8.1 Number of patients diagnosed with neuropathic pain annually |
8.2 Adoption rate of newer treatment modalities for neuropathic pain |
8.3 Patient satisfaction levels with neuropathic pain management services |
9 Egypt Neuropathic Pain Market - Opportunity Assessment |
9.1 Egypt Neuropathic Pain Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Egypt Neuropathic Pain Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Egypt Neuropathic Pain Market Opportunity Assessment, By Procedure, 2021 & 2031F |
9.4 Egypt Neuropathic Pain Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.5 Egypt Neuropathic Pain Market Opportunity Assessment, By Modality, 2021 & 2031F |
9.6 Egypt Neuropathic Pain Market Opportunity Assessment, By Mode of Purchase, 2021 & 2031F |
9.7 Egypt Neuropathic Pain Market Opportunity Assessment, By Pain Type, 2021 & 2031F |
9.7 Egypt Neuropathic Pain Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 Egypt Neuropathic Pain Market - Competitive Landscape |
10.1 Egypt Neuropathic Pain Market Revenue Share, By Companies, 2024 |
10.2 Egypt Neuropathic Pain Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here